(480) 923-0802

Episode 49: Our Take May–Part 1

May 16, 2019


In this week’s episode, John talks EHRs and physician burnout, prescription drug prices in TV ads, and more.

Highlights include:

  • Gundersen Health System and Marshfield Clinic talk merger.
  • Bon Secours Mercy Health signs letter of intent to acquire Dublin, Ireland-based Bon Secours Health System.
  • UnitedHealthcare’s new bundled payment program for maternity care.
  • U.S. District Court judge struck down the 340B rate cut.
  • Washington becomes the second state to announce a subscription-based payment model for HCV drugs.

In this episode

John Marchica

John Marchica is a veteran health care strategist and CEO of Darwin Research Group. He was the founder and CEO of FaxWatch, a leading business intelligence and medical education company and two-time member of the Inc. 500 list of America's fastest growing companies.

John is the author of The Accountable Organization and has advised senior management on strategy and organizational change for more than a decade. John earned his B.A. in economics from Knox College, an MBA and M.A. in public policy from The University of Chicago, and completed his Ph.D. coursework and doctoral exams in clinical epidemiology and health economics at The Dartmouth Institute for Health Policy and Clinical Practice. He is a faculty associate in the W.P. Carey School of Business and the College of Health Solutions at Arizona State University.

About Darwin Research Group

Darwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin’s client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.


Contact Darwin Research Group and we will get right back to you.